6 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
and strategy ESG initiatives These meetings were attended by the Independent Chair of our Compensation Committee and members of our management team
CONTINUING
DEF 14A
VIR
Vir Biotechnology Inc
6 Apr 20
Definitive proxy
4:52pm
Dr. Scangos and Dr. Frueh, had a material or other disqualifying relationship with us.
Board Leadership Structure
Our Board has an independent chair, Dr
- Prev
- 1
- Next